These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8427828)

  • 1. A case of xeroderma pigmentosum complementation group F with neurological abnormalities.
    Moriwaki S; Nishigori C; Imamura S; Yagi T; Takahashi C; Fujimoto N; Takebe H
    Br J Dermatol; 1993 Jan; 128(1):91-4. PubMed ID: 8427828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
    Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
    Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeroderma pigmentosum complementation group E: a case report.
    Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum group D patient bearing lentigo maligna without neurological symptoms.
    Fukuro S; Yamaguchi J; Mamada A; Kondo S; Satoh Y
    Dermatologica; 1990; 181(2):129-33. PubMed ID: 2242781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and photobiological characteristics of xeroderma pigmentosum complementation group F: a review of cases from Japan.
    Yamamura K; Ichihashi M; Hiramoto T; Ogoshi M; Nishioka K; Fujiwara Y
    Br J Dermatol; 1989 Oct; 121(4):471-80. PubMed ID: 2696553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seventh complementation group in excision-deficient xeroderma pigmentosum.
    Keijzer W; Jaspers NG; Abrahams PJ; Taylor AM; Arlett CF; Zelle B; Takebe H; Kinmont PD; Bootsma D
    Mutat Res; 1979 Aug; 62(1):183-90. PubMed ID: 492197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assignment of six patients with xeroderma pigmentosum in Hokkaido area to a variant form.
    Fujikawa K; Ayaki H; Ishizaki K; Takatera H; Matsuo S; Iizuka H; Koizumi H; Ikenaga M
    J Radiat Res; 1994 Sep; 35(3):168-78. PubMed ID: 7830260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No apparent neurologic defect in a patient with xeroderma pigmentosum complementation group D.
    Ichihashi M; Yamamura K; Hiramoto T; Fujiwara Y
    Arch Dermatol; 1988 Feb; 124(2):256-60. PubMed ID: 3341805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
    Thielmann HW; Popanda O; Edler L; Jung EG
    Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.
    Andrews AD; Barrett SF; Robbins JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1984-8. PubMed ID: 273925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ninth complementation group in xeroderma pigmentosum, XP I.
    Fischer E; Keijzer W; Thielmann HW; Popanda O; Bohnert E; Edler L; Jung EG; Bootsma D
    Mutat Res; 1985 May; 145(3):217-25. PubMed ID: 3982437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum complementation group G--report of two cases.
    Norris PG; Hawk JL; Avery JA; Giannelli F
    Br J Dermatol; 1987 Jun; 116(6):861-6. PubMed ID: 3620347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
    Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
    J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
    Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
    Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium butyrate stimulates cellular recovery from UV damage in xeroderma pigmentosum cells belonging to complementation group F.
    Nishigori C; Takebe H
    Jpn J Cancer Res; 1987 Sep; 78(9):932-6. PubMed ID: 3117749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
    Yamashita T; Okura M; Ishii-Osai Y; Hida T
    J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum complementation group F in a non-Japanese patient.
    Norris PG; Hawk JL; Avery JA; Giannelli F
    J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1185-8. PubMed ID: 3372781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DNA repair defect in a patient with ataxia, mental retardation, and short stature.
    Yamagata T; Momoi MY; Saitoh S; Takadaya K; Sato K
    Pediatr Neurol; 1998 Apr; 18(4):358-61. PubMed ID: 9588536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.